healthpayerintelligence.com
Open in
urlscan Pro
2606:4700:20::681a:a42
Public Scan
URL:
https://healthpayerintelligence.com/news/how-end-of-phe-will-impact-consumer-covid-19-healthcare-spending-by-coverage-type?eid=CXTEL...
Submission: On October 25 via api from US — Scanned from DE
Submission: On October 25 via api from US — Scanned from DE
Form analysis
7 forms found in the DOMPOST https://healthpayerintelligence.com/news/how-end-of-phe-will-impact-consumer-covid-19-healthcare-spending-by-coverage-type
<form id="cookieConsentForm" method="post" action="https://healthpayerintelligence.com/news/how-end-of-phe-will-impact-consumer-covid-19-healthcare-spending-by-coverage-type">
<div class="hiddenFields">
<input type="hidden" name="ACT" value="116">
<input type="hidden" name="RET" value="Fa5Wq9l7PCAuxyS9i4K/E8JOtW2I3rGYOFJAIZufc34z6t9mJ7BtryYA97ZAkQw16SP0lswDQL7zfRAp4KccLgOGiYuj1eL2w4E7o7/892sr3vjUKJb2aMk+VIH5+CX1fJMaI6Z2xMXiQx/5KUu3Ug==">
<input type="hidden" name="consent_names" value="G4lmiIrLdd8haUsJ8/xguO1cnqFEQ41NTMZF4trTRNjibhnbW58W9Gc/z4JlAtU0">
<input type="hidden" name="site_id" value="9">
<input type="hidden" name="csrf_token" value="0c260b9587d57483a131ba0fc8e0cf436bb85506">
</div>
<div id="cookie-consent">
<div class="msg">
<p>This website uses a variety of cookies, which you consent to if you continue to use this site. You can read our <a href="http://www.xtelligentmedia.com/privacy-policy" target="_blank">privacy policy</a> for details about how these cookies
are used, and to grant or withdraw your consent for certain types of cookies. Consent and dismiss this banner by clicking agree.</p>
</div>
<div class="action">
<input type="hidden" name="terms-of-service" value="y">
<input type="submit" name="submit" value="Agree">
</div>
</div>
</form>
POST https://healthpayerintelligence.com/
<form id="top_search_form" class="form" method="post" action="https://healthpayerintelligence.com/">
<div class="hiddenFields">
<input type="hidden" name="params" value="eyJyZXN1bHRfcGFnZSI6InNlYXJjaFwvaW5kZXgifQ">
<input type="hidden" name="ACT" value="104">
<input type="hidden" name="site_id" value="9">
<input type="hidden" name="csrf_token" value="0c260b9587d57483a131ba0fc8e0cf436bb85506">
</div>
<input type="text" name="keywords" size="20" placeholder="Search..."><input type="image" src="https://healthpayerintelligence.com/misc/search-solid.png" name="submit" value="Search">
</form>
POST https://healthpayerintelligence.com/
<form id="search_form" class="form" method="post" action="https://healthpayerintelligence.com/">
<div class="hiddenFields">
<input type="hidden" name="params" value="eyJyZXN1bHRfcGFnZSI6InNlYXJjaFwvaW5kZXgifQ">
<input type="hidden" name="ACT" value="104">
<input type="hidden" name="site_id" value="9">
<input type="hidden" name="csrf_token" value="0c260b9587d57483a131ba0fc8e0cf436bb85506">
</div>
<input type="text" name="keywords" size="20" placeholder="Search..."><input type="image" src="https://healthpayerintelligence.com/misc/search.png" name="submit" value="Search">
</form>
POST https://healthpayerintelligence.com/
<form id="xtel-leads-form" method="post" action="https://healthpayerintelligence.com/">
<div class="hiddenFields">
<input type="hidden" name="ACT" value="53">
<input type="hidden" name="RET" value="">
<input type="hidden" name="URI" value="news/how-end-of-phe-will-impact-consumer-covid-19-healthcare-spending-by-coverage-type">
<input type="hidden" name="redirect" value="">
<input type="hidden" name="member_id" value="0">
<input type="hidden" name="site_id" value="9">
<input type="hidden" name="csrf_token" value="0c260b9587d57483a131ba0fc8e0cf436bb85506">
</div>
<input type="text" name="user-email" id="user-email" placeholder="Your email">
<input type="hidden" name="site" id="user-site" value="HealthPayerIntelligence">
<input type="hidden" name="refereer" id="user-refereer" value="https://healthpayerintelligence.com/news/how-end-of-phe-will-impact-consumer-covid-19-healthcare-spending-by-coverage-type">
<input type="hidden" name="action" value="lead">
<input type="hidden" name="elqCustomerGUID" value="">
<input type="hidden" name="elqCookieWrite" value="0">
<p><label for="newsletter-org">Organization Type</label><br><select name="newsletter-org" id="newsletter-org" class="newsletter-org" required="">
<option disabled="" selected="">Select One</option>
<option value="1">Accountable Care Organization</option>
<option value="2">Ancillary Clinical Service Provider</option>
<option value="3">BioMedical Engineering</option>
<option value="4">Biotechnology Company</option>
<option value="5">Clinical Research Organization</option>
<option value="6">Federal/State/Municipal Health Agency</option>
<option value="7">Hospital/Medical Center/Multi-Hospital System/IDN</option>
<option value="8">Life Sciences</option>
<option value="9">Medical Device Manufacturer</option>
<option value="10">Outpatient Center</option>
<option value="11">Payer/Insurance Company/Managed Care Organization</option>
<option value="12">Pharmaceutical Company</option>
<option value="13">Physician Practice/Physician Group</option>
<option value="14">Skilled Nursing Facility</option>
<option value="15">Vendor</option>
</select></p><input type="submit" id="check-email" value="Submit">
</form>
POST https://healthpayerintelligence.com/
<form id="newsletter-form" method="post" action="https://healthpayerintelligence.com/">
<div class="hiddenFields">
<input type="hidden" name="ACT" value="89">
<input type="hidden" name="RET" value="">
<input type="hidden" name="URI" value="news/how-end-of-phe-will-impact-consumer-covid-19-healthcare-spending-by-coverage-type">
<input type="hidden" name="redirect" value="">
<input type="hidden" name="member_id" value="0">
<input type="hidden" name="site_id" value="9">
<input type="hidden" name="csrf_token" value="0c260b9587d57483a131ba0fc8e0cf436bb85506">
</div>
<input type="hidden" name="site" id="user-site" value="HealthPayerIntelligence">
<input type="hidden" name="refereer" id="user-refereer" value="https://healthpayerintelligence.com/news/how-end-of-phe-will-impact-consumer-covid-19-healthcare-spending-by-coverage-type">
<input type="hidden" name="action" value="lead">
<input type="hidden" name="elqCustomerGUID" value="">
<input type="hidden" name="elqCookieWrite" value="0">
<input type="checkbox" name="newsletter-sites[]" value="9" checked=""> Payers, Policy and Employee Wellness<br><input type="checkbox" name="newsletter-sites[]" value="1"> Bio and Pharma News<br><input type="checkbox"
name="newsletter-sites[]" value="5"> RevCycle, Value Based Care and Finance<br><input type="checkbox" name="newsletter-sites[]" value="103"> Medical Imaging<br><input type="checkbox" name="newsletter-sites[]"
value="104"> Behavioral Health<br>
<p><label for="newsletter-org">Organization Type</label><br><select name="newsletter-org" id="newsletter-org" class="newsletter-org" required="">
<option disabled="" selected="">Select One</option>
<option value="1">Accountable Care Organization</option>
<option value="2">Ancillary Clinical Service Provider</option>
<option value="3">BioMedical Engineering</option>
<option value="4">Biotechnology Company</option>
<option value="5">Clinical Research Organization</option>
<option value="6">Federal/State/Municipal Health Agency</option>
<option value="7">Hospital/Medical Center/Multi-Hospital System/IDN</option>
<option value="8">Life Sciences</option>
<option value="9">Medical Device Manufacturer</option>
<option value="10">Outpatient Center</option>
<option value="11">Payer/Insurance Company/Managed Care Organization</option>
<option value="12">Pharmaceutical Company</option>
<option value="13">Physician Practice/Physician Group</option>
<option value="14">Skilled Nursing Facility</option>
<option value="15">Vendor</option>
</select></p><input type="text" id="newsletter-sites-email" name="newsletter-sites-email" placeholder="Your email"><input type="submit" id="newsletter-sites-submit" value="sign up" class="red-button">
</form>
POST https://healthpayerintelligence.com/
<form id="forgot_password_form" method="post" action="https://healthpayerintelligence.com/">
<div class="hiddenFields">
<input type="hidden" name="ACT" value="122">
<input type="hidden" name="RET" value="">
<input type="hidden" name="params_id" value="497224792">
<input type="hidden" name="site_id" value="9">
<input type="hidden" name="csrf_token" value="0c260b9587d57483a131ba0fc8e0cf436bb85506">
</div>
<p>
<label for="email"> Email Address <span class="required">*</span>
</label>
<input type="text" name="email" id="email">
</p>
<p><input type="submit" name="submit" value="Reset password"></p>
</form>
<form id="elq-form"><input type="hidden" name="elqCustomerGUID" value="e7946091-3bd3-48e3-a740-d5ccd074e85a"></form>
Text Content
This website uses a variety of cookies, which you consent to if you continue to use this site. You can read our privacy policy for details about how these cookies are used, and to grant or withdraw your consent for certain types of cookies. Consent and dismiss this banner by clicking agree. * * login | * register * Home * News * Features * Interviews * Podcasts * Research * White Papers & Webcasts * Events * Value-Based Care * Policy & Regulation * Public Payers * Private Payers * Member Experience * Benefits Innovation * Toggle navigation HealthPayerIntelligence * Home * News * Features * Interviews * Podcasts * White Papers & Webcasts * Events * * Become a member * Login * Value-Based Care * Claims Management * Policy & Regulation * Public Payers * Private Payers * Member Experience * Benefits Innovation TopicValue-Based CareClaims ManagementPolicy & RegulationPublic PayersPrivate PayersMember ExperienceBenefits Innovation POLICY AND REGULATION NEWS HOW END OF PHE WILL IMPACT CONSUMER COVID-19 HEALTHCARE SPENDING BY COVERAGE TYPE THE END OF THE PUBLIC HEALTH EMERGENCY AND THE DEPLETION OF FEDERAL TREATMENT, TESTING, AND VACCINE SUPPLIES WILL INFLUENCE CONSUMER HEALTHCARE SPENDING DEPENDING ON THE COVERAGE TYPE. Source: Getty Images Share on Twitter By Kelsey Waddill October 19, 2022 - Federal funding was crucial in enhancing access to coronavirus resources during the initial phases of the pandemic, but questions remain about what will occur when the public health emergency ends and how it will impact consumer healthcare spending, according to a Kaiser Family Foundation brief. The end of the public health emergency is still undetermined. However, experts have projected that it will end in 2023. The scheduled termination has been pushed back multiple times. Its final termination will signal the end of various flexibilities and protections that have been tied to the declaration. But in addition to the public health emergency, the federally purchased supply of coronavirus-related products is running low and policymakers have offered a solution. DIG DEEPER * HHS Procures Federally-Covered COVID-19 Treatment Doses For Uninsured * Concerns about Cost of Healthcare Supersede COVID-19 Concerns in MA * How One Medicaid Program May Prevent Coverage Loss Post-COVID Coronavirus vaccines are protected from the end of the public health emergency. However, these issues could produce challenges for treatment and testing access. “These access challenges will also vary by payer, with the uninsured and the underinsured standing to lose the most,” the researchers found. “Whereas these products will continue to be covered by both public and private insurance after the federal supply is depleted and the PHE protection period is over, albeit in some cases with cost sharing, this is not the case for adults who are uninsured, who will have limited access to free vaccines, and no coverage for the cost of treatments and tests.” For vaccines, individuals on short-term health insurance plans and uninsured individuals are most likely to have to pay full cost for the drug when federal supplies run out. The program that has been established to help cover uninsured adults’ coronavirus vaccines when the public health emergency ends will have limited availability. The Biden administration has included in its fiscal year 2023 budget request a recommendation to create a program that covers coronavirus vaccines for uninsured adults. For coronavirus treatment, Medicare beneficiaries face a high risk and may also face a higher cost when the public health emergency ends. Oral antiviral treatments are covered under Medicare Part D, but cost may vary broadly after the declaration is over. Medicare does not have to cover these treatments until they get FDA approval. In Medicaid and Children’s Health Insurance Program (CHIP), all programs must cover drugs and biological products for coronavirus treatment and prevention for free for eligible beneficiaries until the end of the first quarter in the year after the public health emergency ends. But after that, the coverage policies will vary widely. Private payer members may see a slight uptick in their premium payments when the federal supplies run out. Providers who treat uninsured individuals for coronavirus will be able to use government-purchased supplies until they run out. HHS has procured 60,000 doses of bebtelovimab, a coronavirus treatment, for the uninsured and underinsured. This store is expected to last through September 2023. The drug has been transitioned to the commercial market. For coronavirus testing, Medicare beneficiaries and the uninsured will have to cover the full cost of at-home tests after the public health emergency ends. Medicaid and CHIP programs will have to cover testing as a mandatory lab service, given the right approvals. States can go beyond this rule and cover the test regardless of the provider’s approval, but that would be up to the state. Private payer members will likely face some amount of cost-sharing. “Depending on the type of product (vaccines/boosters, treatments, or tests) and insurance coverage (Medicare, Medicaid/CHIP, private, or uninsured/underinsured), access problems could come in the form of new or higher cost sharing, more limited coverage, or both,” the researchers found. * Tagged * CHIP * Coronavirus * Healthcare Spending * Medicaid * Medicare Share on Twitter RELATED ARTICLES * Private Payer Spending Hits $1.2T in 2019 As Spending Growth Slows * CMS Releases Vaccine Coverage Plan, Medicare Reimbursement Rate * 87% of Eligible Seniors Do Not Receive Lung Cancer Screenings RELATED RESOURCES * Innovative Approaches to Patient Engagement through AWS Marketplace * Analytic Solutions for Value-Based Care * Optimizing Analytic Solutions for Value-Based Care SIGN UP TO RECEIVE OUR NEWSLETTER AND ACCESS OUR RESOURCES Organization Type Select OneAccountable Care OrganizationAncillary Clinical Service ProviderBioMedical EngineeringBiotechnology CompanyClinical Research OrganizationFederal/State/Municipal Health AgencyHospital/Medical Center/Multi-Hospital System/IDNLife SciencesMedical Device ManufacturerOutpatient CenterPayer/Insurance Company/Managed Care OrganizationPharmaceutical CompanyPhysician Practice/Physician GroupSkilled Nursing FacilityVendor Newsletter Signup Sign up to receive our newsletter and access our resources Payers, Policy and Employee Wellness Bio and Pharma News RevCycle, Value Based Care and Finance Medical Imaging Behavioral Health Organization Type Select OneAccountable Care OrganizationAncillary Clinical Service ProviderBioMedical EngineeringBiotechnology CompanyClinical Research OrganizationFederal/State/Municipal Health AgencyHospital/Medical Center/Multi-Hospital System/IDNLife SciencesMedical Device ManufacturerOutpatient CenterPayer/Insurance Company/Managed Care OrganizationPharmaceutical CompanyPhysician Practice/Physician GroupSkilled Nursing FacilityVendor view our privacy policy Most Read Stories * Top 10 Most Expensive Chronic Diseases for Healthcare Payers * Judge Finalizes Blue Cross Blue Shield Antitrust Settlement * CMS: Medicare Part B Premiums, Deductibles Will Decrease in 2023 * Top 5 Largest Health Insurers in the US by National Market Share Popular Topics * Healthcare Payers * Affordable Care Act * Healthcare Spending * Medicaid * CMS * Policy and Regulation * Value-based Care * Medicare * Value-Based Contracting * Medicare Advantage Most Read Features * How One Payer Expanded the Boundaries of Maternal Healthcare Benefits * How the Inflation Reduction Act Will Impact Employers, Health Plans * 5 Strategies for 5 Stars: Cigna's Approach to CMS Star Ratings * The Progress and Challenges of the Affordable Care Act BECOME A MEMBER Complete your profile below to access this resource. Thanks for subscribing to our newsletter. Please fill out the form below to become a member and gain access to our resources. RESET YOUR PASSWORD Enter your email address to receive a link to reset your password Email Address * NEXT IN POLICY AND REGULATION HHS Finalizes Rule That Aims to Fix the Affordable Care Act Family Glitch * About Us * Contact Us * Advertise on HealthPayerIntelligence * Privacy Policy * DMCA Policy * Terms & Condition * Sitemap * EHRIntelligence * HealthITSecurity * HealthITAnalytics * RevCycleIntelligence * mHealthIntelligence * HITInfrastructure * PatientEngagementHIT * PharmaNewsIntelligence * HealthCareExecIntelligence * LifeSciencesIntelligence ©2012-2022 TechTarget, Inc. Xtelligent Healthcare Media is a division of TechTarget. All rights reserved. HealthPayerIntelligence.com is published by Xtelligent Healthcare Media a division of TechTarget.